Skip to main
BBNX
BBNX logo

BBNX Earnings Dates & Reports

BBNX Most Recent Earnings

Report DateJul 29, 2025
Period EndingQ2 2025
Est. EPS-$0.48
Actual EPS-$0.39
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

BBNX Earnings per Share (EPS) History

Signup for full access
Browse free

BBNX Latest Earnings

The value each BBNX share was expected to gain vs. the value each share gained.

BBNX reported its most recent earnings on Jul 29, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.39. This exceeded analysts' expectations of -$0.48 by 18.75%, marking a Beat.

For comparison, Beta Bionics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 07/28/2026, with analysts projecting an EPS of $0.

BBNX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026Jul 28, 2026
Next earnings call Jul. 28, 2026
Q2 2025Jul 29, 2025
-$0.48-$0.39-18.75%
DeckReportListen

BBNX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Beta Bionics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Jul 29, 2025

BBNX Earnings FAQs

BBNX last reported earnings on Jul 29, 2025 for Q2 2025, posting an EPS of -$0.39, which Beat the estimate of -$0.48 by 18.75%.

For Q2 2025, BBNX reported an EPS of -$0.39, exceeding analysts' estimate of -$0.48 by 18.75%.

For Q2 2025, BBNX Beat expectations with an actual EPS of -$0.39 vs. an estimated EPS of -$0.48.

Following the last earnings report on Jul 29, 2025, BBNX's stock price moved — from — to —.

The next BBNX earnings call is scheduled for Jul. 28, 2026, where executives will discuss financial results and outlook.

Beta Bionics Inc (BBNX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.